Company Filing History:
Years Active: 1977-2004
Title: Milan Bier: Innovator in Isoelectric Focusing and Immunotherapy
Introduction
Milan Bier is a notable inventor based in Tucson, Arizona, with a remarkable portfolio of 14 patents. His work primarily focuses on advancements in isoelectric focusing technology and oral immunotherapy for gastrointestinal disorders.
Latest Patents
Among his latest patents is the "Variable-volume disposable isoelectric focusing cell and method of isoelectric focusing." This invention utilizes an elastomeric cell as a disposable component for isoelectric focusing in free solution, accommodating volumes between 0.5 to 5 ml. The design includes an inlet port for priming and end-connectors for electrode coupling. A grid of parallel rods compresses the cell against a cold plate, facilitating the formation of fluid bubble-compartments for effective IEF separation. The invention also allows for the collection of separated fractions using syringe-like devices.
Another significant patent is the "Oral immunotherapy of bacterial overgrowth." This invention focuses on the oral administration of animal immunoglobulins to treat gastrointestinal disorders caused by bacterial and yeast overgrowth. Immunoglobulins derived from various animals contain a broad spectrum of antibodies that can effectively address gastrointestinal issues in human patients.
Career Highlights
Milan Bier has contributed to the field through his work with companies such as University Patents, Inc. and Protein Technologies, Inc. His innovative approaches have significantly impacted the development of medical technologies.
Collaborations
Milan has collaborated with notable individuals in his field, including Terry D Long and Rodolfo Bacheleir Marquez. These partnerships have further enhanced his contributions to innovation.
Conclusion
Milan Bier's inventive spirit and dedication to advancing medical technology are evident in his numerous patents and collaborations. His work continues to influence the fields of isoelectric focusing and immunotherapy, showcasing the importance of innovation in addressing health challenges.